OpenAI Researcher Miles Wang Eyes $2B AI Drug Discovery Startup
OpenAI researcher Miles Wang is in advanced talks to spin out and launch an AI-powered drug discovery startup at a…
Tag: drug
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B | TechCrunch
Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT…
Enoda unveils drug development platform – TechCentral.ie
Joint UCD and Newcastle University spin-out emerges from €50m pan-European Mobilise-D project Trade Michael McMahon, Enoda Healthtech start-up Enoda has…
Reid Hoffman Exits Microsoft Board for AI Drug Startup
Reid Hoffman is walking away from one of tech’s most prestigious board seats. The LinkedIn co-founder and legendary venture capitalist…
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
Chai Discovery cofounders Josh Meier (left) and Jack Dent Cody Pickens for Forbes L ast June, when AI drug discovery…
Quantum computing for drug discovery still hasn’t had its “ChatGPT moment,” biotech founder says | BetaKit
ProteinQure’s co-founder argues “messy biology experiments” are still the bottleneck. Quantum chemistry has been touted as having the potential…
AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days — TFN
New York-based Solstice raised $21M in Series A funding led by Transformation Capital, bringing total funding to nearly $25M The…
California startup Protuoso raises $9.5m for “mix-and-match” drug platform
Protuoso Biosciences has secured $9.5m in seed financing to develop its platform which combines multiple therapeutic modalities to target diseases…
University of Toronto – AI startup founded by U of T alumni to revive failed drug candidates
A startup founded by University of Toronto alumni has won Silicon Valley buy-in for its novel approach to AI-assisted drug…
Lilly to buy startup Ajax in bid for a better JAK drug
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma…
AI drug discovery race, PIF's LIV Golf pullback, and Thoma Bravo's Google deal – Axios
AI drug discovery race, PIF’s LIV Golf pullback, and Thoma Bravo’s Google deal Axios Source link
B Capital By AMED To Support Japan Drug Development Ecosystem
B Capital announced it has been selected as a registered venture capital firm under the Agency for Medical Research and…
Bengaluru Startup Peptris Bags $7.7Mn in Funding to Scale AI-driven Drug Discovery
• 6 hours ago • 3 Mins Read The platform integrates advanced AI to predict molecular behavior, identify potential drug…
Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic – MedCity News
Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line…
Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug – MedCity News
Alzheimer’s disease can be treated with antibodies that clear away plaques of amyloid protein, but these medicines require frequent dosing…
Takeda Taps AI Startup Iambic In $1.7 Billion+ Deal To Speed Up Drug Discovery – Takeda Pharmaceutical Co (NYSE:TAK)
AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited (NYSE:TAK). The…
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development | TechCrunch
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques,…
AI healthcare enters a golden era of development! NVIDIA and Eli Lilly and Co invest in AI-driven drug discovery, while OpenAI acquires healthcare startup Torch.
AI healthcare concept stocks in the Hong Kong stock market collectively surged, $FANGZHOU JIANKE (06086.HK)$ with some rising over 36%,…